Cargando…
Outcome of SARS-CoV-2-Infected Polish Patients with Chronic Lymphocytic Leukemia
SIMPLE SUMMARY: The severe acute respiratory syndrome coronavirus (SARS-CoV-2) has become the cause of a worldwide pandemic, and its clinical infection course in patients with hematological malignancies may be severe. Chronic lymphocytic leukemia (CLL) patients are among this group, and CLL-directed...
Autores principales: | Puła, Bartosz, Pruszczyk, Katarzyna, Pietrusza, Ewa, Morawska, Marta, Piszczek, Weronika, Kalicińska, Elżbieta, Szeremet, Agnieszka, Tryc-Szponder, Jagoda, Wąsik-Szczepanek, Ewa, Drozd-Sokołowska, Joanna, Krzemień, Helena, Rejus, Aleksandra, Gajewska, Małgorzata, Wiśniewski, Kamil, Wysocki, Maciej, Majeranowski, Alan, Paszkiewicz-Kozik, Ewa, Steckiewicz, Paweł, Szukalski, Łukasz, Bołkun, Łukasz, Długosz-Danecka, Monika, Giannopoulos, Krzysztof, Jamroziak, Krzysztof, Lech-Marańda, Ewa, Hus, Iwona |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833688/ https://www.ncbi.nlm.nih.gov/pubmed/35158826 http://dx.doi.org/10.3390/cancers14030558 |
Ejemplares similares
-
Clinical efficacy and tolerability of venetoclax plus rituximab in patients with relapsed or refractory chronic lymphocytic leukemia—a real-world analysis of the Polish Adult Leukemia Study Group
por: Soboń, Anita, et al.
Publicado: (2023) -
P1221: DIFFUSE LARGE B-CELL LYMPHOMA RICHTER SYNDROME IN CHRONIC LYMPHOCYTIC LEUKEMIA – A RETROSPECTIVE ANALYSIS OF TREATMENT OUTCOMES IN POLISH ADULT LEUKEMIA STUDY GROUP
por: Sośnia, O., et al.
Publicado: (2022) -
P1103: OBINUTUZUMAB INDUCTION AND MAINTENANCE IN PATIENTS WITH RELAPSED/REFRACTORY WALDENSTRÖM MACROGLOBULINAEMIA
por: Wróbel, Tomasz, et al.
Publicado: (2023) -
Immunophenotypic Characteristics of Bone Marrow Microenvironment Cellular Composition at the Biochemical Progression of Multiple Myeloma
por: Krzywdzińska, Agnieszka, et al.
Publicado: (2022) -
Mean Platelet Volume Has Prognostic Value in Chronic Lymphocytic Leukemia
por: Masternak, Marta, et al.
Publicado: (2020)